Long term, prospective, non-interventional, multicenter, double-blinded parallel-cohort study monitoring effectiveness and tolerability of teriflunomide (Aubagio®) in the progress of disability in patients with MS

dc.contributor.advisor	Χατζηγεωργίου, Γεώργιος	el
dc.creator	Κουτουκόγλου, Πρόδρομος	el
dc.date.accessioned	2017-05-05T09:05:03Z
dc.date.available	2017-05-05T09:05:03Z
dc.date.issued	2016
dc.identifier.other	15246
dc.identifier.uri	http://hdl.handle.net/11615/46386
dc.identifier.uri	http://dx.doi.org/10.26253/heal.uth.4246
dc.language.iso	en	en
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International	en
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	en
dc.subject.other	Σκλήρυνση κατά πλάκας	el
dc.title	Long term, prospective, non-interventional, multicenter, double-blinded parallel-cohort study monitoring effectiveness and tolerability of teriflunomide (Aubagio®) in the progress of disability in patients with MS	en
dc.type	masterThesis	en
heal.recordProvider	Πανεπιστήμιο Θεσσαλίας - Βιβλιοθήκη και Κέντρο Πληροφόρησης	el
heal.academicPublisher	Πανεπιστήμιο Θεσσαλίας. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής.	el
heal.academicPublisherID	uth	en
heal.fullTextAvailability	true	en
dc.rights.accessRights	free	en

Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International